INYX UPDATES FINANCIAL GUIDANCE FOR 2005 AND 2006

Inyx, Inc. (OTC Bulletin Board: IYXI -- News), a specialty pharmaceutical company with a focus on niche drug delivery technologies and products, today reported updated financial guidance for 2005 and 2006. "As a result of our company's strategic United Kingdom acquisition of the Celltech manufacturing operation two weeks ago and our strategic alliance with King Pharmaceuticals announced last week, Inyx's industry positioning has changed and been enhanced significantly. Inyx's mid-term financial outlook also has been increased materially," said Jack Kachkar, M.D., Chairman and Chief Executive Officer of Inyx, Inc.

Yahoo News (http://biz.yahoo.com/prnews/050913/netu030.html?.v=22)